• News
  • SAN DIEGO
  • BioTech

Zogenix objects to new Massachusetts restrictions

A San Diego company that makes the new prescription painkiller Zohydro says it is disappointed with Massachusetts Gov. Deval Patrick's decision to impose new restrictions on the drug after a federal judge said his attempt to ban it outright was unconstitutional.

The new requirements, announced by Patrick on Tuesday, include the doctor's completion of a risk assessment and a “pain management treatment agreement” with the patient before prescribing drugs like Zohydro.

Drugmaker Zogenix (Nasdaq: ZGNX) said in a statement Wednesday that with the new rules, the governor is continuing to unfairly single out the new drug even as the company maintains the medication is no riskier than other opioids currently on the market.

“Imposing restrictions on one specific treatment without developing a full understanding of the facts and the causes of the problem does not serve the public interest,” the statement said.

The company also said Patrick has not accepted its offer to discuss the issue and to work together to address the needs of patients and the problem of illegal drug use.

Neither Patrick nor the state public health commissioner immediately responded to requests for comment.

A federal judge last week blocked the state from enforcing an outright ban, which the governor issued through an executive order in March in response to a surge of drug overdoses and deaths in the state.

Zohydro contains up to five times the amount of narcotic hydrocodone previously available in pills, and some health officials say the drug can be easily crushed and then inhaled or injected, making it susceptible to abuse.

Leave Your Comment

Comments are moderated by SDDT, in accordance with the SDDT Comment Policy, and may not appear on this commentary until they have been reviewed and deemed appropriate for posting. Also, due to the volume of comments we receive, not all comments will be posted.

SDDT Comment Policy: SDDT encourages you to add a comment to this discussion. You may not post any unlawful, threatening, defamatory, obscene, pornographic or other material that would violate the law. All comments should be relevant to the topic and remain respectful of other authors and commenters. You are solely responsible for your own comments, the consequences of posting those comments, and the consequences of any reliance by you on the comments of others. By submitting your comment, you hereby give SDDT the right, but not the obligation, to post, air, edit, exhibit, telecast, cablecast, webcast, re-use, publish, reproduce, use, license, print, distribute or otherwise use your comment(s) and accompanying personal identifying and other information you provide via all forms of media now known or hereafter devised, worldwide, in perpetuity. SDDT Privacy Statement.

User Response
0 UserComments

Leave Your Comment

Comments are moderated by SDDT, in accordance with the SDDT Comment Policy, and may not appear on this commentary until they have been reviewed and deemed appropriate for posting. Also, due to the volume of comments we receive, not all comments will be posted.

SDDT Comment Policy: SDDT encourages you to add a comment to this discussion. You may not post any unlawful, threatening, defamatory, obscene, pornographic or other material that would violate the law. All comments should be relevant to the topic and remain respectful of other authors and commenters. You are solely responsible for your own comments, the consequences of posting those comments, and the consequences of any reliance by you on the comments of others. By submitting your comment, you hereby give SDDT the right, but not the obligation, to post, air, edit, exhibit, telecast, cablecast, webcast, re-use, publish, reproduce, use, license, print, distribute or otherwise use your comment(s) and accompanying personal identifying and other information you provide via all forms of media now known or hereafter devised, worldwide, in perpetuity. SDDT Privacy Statement.

Zogenix Inc.

Company Website

12400 High Bluff Dr. Ste., 650
San Diego, CA 92130

Company Trade Data

Stock Symbol Close
Change
Chg %Chg
Volume
52-Week
High Low
ZGNX
13.53
  -0.06  
- 0.44%
335,635,000
21.65
8.64

Zogenix Inc. Executive(s):

Roger Hawley

  • Chief Executive Officer

Stephen Farr

  • President

Ann Rhoads

  • Chief Financial Officer